Four vs 6 Cycles of Doxorubicin and Cyclophosphamide (AC) or Paclitaxel (T) as Adjuvant Therapy for Breast Cancer in Women with 0-3 Positive Axillary Nodes: CALGB 40101 A 2x2 Factorial Phase III Trial: First Results Comparing 4 vs 6 Cycles of Therapy.
- Citation:
- CANCER RESEARCH vol 70 (24_Supplement) S6-3.
- Meeting Instance:
- SABCS 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 788
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- L. N. Shulman C. T. Cirrincione D. A. Berry H. P. Becker E. Perez R. O'Regan S. Martino J. N. Atkins C. Hudis E. Winer
- Networks:
- Study
- CALGB-40101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: